Frontlight ResearchEarly access
Trial site
Liverpool
- 5running trials
- 4closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease2 trials
- Multiple sclerosis2 trials
- Stroke2 trials
- Diabetic eye disease1 trial
- Familial hypercholesterolaemia1 trial
- Giant cell arteritis1 trial
- IgA nephropathy1 trial
- Prostate cancer1 trial
- Phase
- Phase 38 trials
- Phase 1/21 trial
- Status
- Active, not recruiting4 trials
- Completed3 trials
- Recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Novartis Pharmaceuticals9 trials
Running trials
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Prostate cancer1 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026